Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
N Engl J Med 2025;393:26-36
Cm:n, Carnitine, in which m is the number of carbon atoms, n is the unsaturation
The disease can damage any part of the body
Public Health Recommendations The CPHA article outlines three recommendations for the public health sector: Addressing industry influence and the commercial determinants of health, including engagement in policy reform around drug pricing, regulation, and access [Source: cpha.ca/glp-1-agonists-and-obesity-public-health-perspective] Strengthening evidence and surveillance to track GLP-1 use, access, outcomes, and inequities [Source: cpha.ca/glp-1-agonists-and-obesity-public-health-perspective] Countering misinformation through knowledge translation and health education initiatives [Source: cpha.ca/glp-1-agonists-and-obesity-public-health-perspective] The author writes that long-term effectiveness of GLP-1 drugs in everyday use remains uncertain, including whether changes are sustained and what happens after stopping treatment [Source: cpha.ca/glp-1-agonists-and-obesity-public-health-perspective]
US$ 20.46
US$ 22.59
US$ 27.99
US$ 20.65
US$ 23.83
US$ 28.72
US$ 20.73
US$ 21.15
US$ 22.37
US$ 28.37
